Matteo Vitale

Mr. Matteo Vitale

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MVMatteo Vitale
Matteo Vitale
Joaquin Gomez EstacaJoaquin Gomez Estaca
Joaquin Gomez Estaca
JCJanete Chung
Janete Chung
SCSeong-Chea Chua
Seong-Chea Chua
DPDaniela M. Pampanin
Daniela M. Pampanin
Herein, the effectiveness of astaxanthin (AX) as functional feed ingredient was assessed by enhancing its stability and bioavailability using encapsulation methods. Spray-drying and liposome entrapment were applied to a natural AX source from shrimp by-products, along with two commercially synthetic alternatives. Encapsulated AX formulations were evaluated for their physico-chemical properties, thermal stability, and in vitro performance using RTL-W1, a rainbow trout (Oncorhynchus mykiss) liver-derived cell line. Both techniques achieved high encapsulation efficiency (73–89%) and provided remarkable protection to AX during thermal treatments, maintaining its stability at 80 °C for up to 2 h and at 100 °C for 30 min. Nevertheless, neither encapsulation methods significantly mitigated water absorption over time. Additionally, morphological characterization revealed spray-dried microcapsules with typical round, partially collapsed particles with a broad size distribution, while liposomes further stabilized into dry powders by spray-drying showed structural rearrangements and an increase in size upon rehydration, although maintaining a uniform and stable distribution. In vitro testing revealed enhanced RTL-W1 cell viability and reduced reactive oxygen species (ROS) production when encapsulation was employed. Overall, these findings demonstrate the potential of the selected encapsulation techniques to optimize the stability, bioavailability, and functionality of AX, providing valuable insights to improve its utilization as a functional ingredient in fish feed formulations.


20 June 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MVMatteo Vitale
Matteo Vitale
EHEirik Hoel
Eirik Hoel
MYMuhammad Naveed Yousaf
Muhammad Naveed Yousaf
MKMartha Amalie Kambestad
Martha Amalie Kambestad
JMJulia Mullins
Julia Mullins
DPDaniela Maria Pampanin
Daniela Maria Pampanin
Herein, the feasibility of in vitro methods for screening the qualities of functional feed ingredients using the fish cell line RTgill-W1 and the culture of Paramoeba perurans was investigated. Five functional ingredients (arginine, β-glucan, vitamin C, and two phytogenic feed additives) were selected to investigate their effects on cell viability and reactive oxygen species production. Three of them (arginine and two phytogenic feed additives) were additionally tested to assess their potential amoebicidal activity. As these functional ingredients are the core of a commercial feed (Protec Gill, Skretting AS), beneficial effects were further assessed in a field trial using Atlantic salmon (Salmo salar), affected by complex gill disease (CGD). Threshold levels of the ingredient concentrations were identified through RTgill-W1 cell viability assay. High concentrations of all tested ingredients, except vitamin C, resulted in a significant reduction of cell viability. Different effects on reactive oxygen species production were observed among the ingredients. Arginine and two phytogenic feed additives exhibited also pronounced amoebicidal activity at the highest tested concentrations. In the field study, three weeks of feeding Protec Gill slowed the disease progression, and also led to a significant improvement in gill tissue conditions. Significant reductions of epithelial and mucous hyperplasia, predominant symptoms in fish affected by CGD, and pathogen load, particularly epitheliocystis associated with Ca. Branchiomonas cysticola, one of the major contributors of CGD, were observed. These positive outcomes underscore the potential of functional feed ingredients in ameliorating gill diseases and enhance fish health. RTgill-W1 cell line assays proved to be effective tools for screening functional ingredients, providing valuable insights into optimal concentration ranges. Implementing an in vitro cell-based approach, with additional assays and cell line types, it’s a promising alternative to reduce the number of animals used during fish trials, for a more sustainable aquaculture practice.

21 May 2026 in Aquatic Toxicology
Verified
Journal Article
Open access
MPMichela Panni
Michela Panni
MMMarica Mezzelani
Marica Mezzelani
GDGiuseppe D’ERrico
Giuseppe D’ERrico
MVMatteo Vitale
Matteo Vitale
MBMaura Benedetti
Maura Benedetti
FRFrancesco Regoli
Francesco Regoli
Pharmaceuticals are ubiquitously detected in all environmental matrices and the continuous exposure of non-target aquatic species can impair their metabolic pathways, leading to unknown long-term effects. In this study, the ecotoxicological potential of 16 environmental pharmaceuticals and 7 mixtures (psychiatric, cardiovascular, lipid-lowering, non-steroidal antinflammatory drugs, and antidiabetics) were evaluated in 6 different biological models. In vivo ecotoxicological bioassays (algal growth inhibition, oyster and sea urchin embryotoxicity, bacterial bioluminescence inhibition) were combined to in vitro tests on fish hepatic (PLHC-1) and gill (RTgill-W1) cell lines. A quantitative Weight of Evidence approach was applied to better compare the biological significance of all tested experimental conditions. Results on ecotoxicological bioassays demonstrated different sensitivity of the tested species, with higher effects observed in terms of embryotoxicity and/or algal growth inhibition. Among cell lines, PLHC-1 exhibited selective toxicity towards specific active principles, whereas RTgill-W1 showed broader susceptibility. Psychiatric drugs were the most reactive therapeutic class in all biological models, whereas atenolol, naproxen, paroxetine, venlafaxine and carbamazepine-10,11-epoxide exhibited the greatest toxicity among all investigated compounds. Despite this study did not support a formal mixture-toxicity framework, mixture responses varied among combinations and models, and composition appeared more important than mixture size under the tested conditions. Overall, the selected biological models exhibited distinct species-specific response patterns following mixture exposure. By integrating measured effects into synthetic hazard indices, the quantitative Weight of Evidence approach demonstrated the potential of effect-based tools to prioritize future studies on environmental pharmaceuticals.